2,5-ANHYDRO-1,3,4-TRIDEOXY-2-C-(2,4-DIFLUOROPHENYL)-4-((4-(4-(4-((PHENOXYCARBONYL)AMINO)PHENYL)-1-PIPERAZINYL)PHENOXY)METHYL)-1-(1H-1,2,4-TRIAZOL-1-YL)-D-THREO-PENTITOL
UNII VC99PC96FK
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,5-anhydro-1,3,4-trideoxy-2-c-(2,4-difluorophenyl)-4-((4-(4-(4-((phenoxycarbonyl)amino)phenyl)-1-piperazinyl)phenoxy)methyl)-1-(1h-1,2,4-triazol-1-yl)-d-threo-pentitol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VC99PC96FK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 161532-54-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H36F2N6O4 ZNIXQDWBCJAWHX-AYAMJOBCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,5-anhydro-1,3,4-trideoxy-2-c-(2,4-difluorophenyl)-4-((4-(4-(4-((phenoxycarbonyl)amino)phenyl)-1-piperazinyl)phenoxy)methyl)-1-(1h-1,2,4-triazol-1-yl)-d-threo-pentitol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.